Evidence map›Paper›PMID 38503831›Full record

ArticleScientific reports2024

Effect of chronic vapor nicotine exposure on affective and cognitive behavior in male mice.

Laura B Murdaugh, Cristina Miliano, Irene Chen, Christine L Faunce, Luis A Natividad, Ann M Gregus, Matthew W Buczynski

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Laura B Murdaugh *School of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA.
Cristina Miliano *School of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA.
Irene ChenSchool of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA.
Christine L FaunceSchool of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA.
Luis A NatividadCollege of Pharmacy, Division of Pharmacology and Toxicology, University of Texas at Austin, Austin, TX, USA.
Ann M GregusSchool of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA. agregus@vt.edu.
Matthew W BuczynskiSchool of Neuroscience, Virginia Polytechnic Institute and State University, 970 Washington St SW, Life Sciences I, Blacksburg, VA, 24061, USA. mwb@vt.edu.
Virginia Tech · USThe University of Texas at Austin · US

Funding

15-LOX-1 as a druggable target in the acute to chronic pain transition of rheumatoid arthritisR01AR075241 · NIAMS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI GREGUS, ANN MARIE · 2019 to 2023
$1.7M
Anti-nociceptive actions of CART II in chemotherapy-induced peripheral neuropathyR01CA284075 · NCI · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Matthew Wallace Buczynski · 2023 to 2026
$1.4M
Identification of novel mechanisms in alcohol-induced cognitive dysfunctionR00AA025393 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI NATIVIDAD, LUIS ALBERTO · 2020 to 2022
$747k
The role of the OEA synthase NAPE-PLD in nicotine signaling and rewardR00DA035865 · NIDA · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI BUCZYNSKI, MATTHEW WALLACE · 2017 to 2019
$747k
Investigation of non-canonical opioid signaling in the prefrontal cortex of alcohol-dependent ratsR21AA030862 · NIAAA · UNIVERSITY OF TEXAS AT AUSTIN · PI NATIVIDAD, LUIS ALBERTO · 2023 to 2024
$417k
NCI NIH HHS R01 CA284075NIAAA NIH HHS R00 AA025393NIAAA NIH HHS R21 AA030862NIAMS NIH HHS R01 AR075241NIDA NIH HHS R00 DA035865NIH HHS R00AA025393NIH HHS R00DA035865NIH HHS R01AR075241
6 · The paper itself

Abstract

Nicotine use is a leading cause of preventable deaths worldwide, and most of those who attempt to quit will relapse. While electronic cigarettes and other electronic nicotine delivery systems (ENDS) were presented as a safer alternative to traditional cigarettes and promoted as devices to help traditional tobacco smokers reduce or quit smoking, they have instead contributed to increasing nicotine use among youths. Despite this, ENDS also represent a useful tool to create novel preclinical animal models of nicotine exposure that more accurately represent human nicotine use. In this study, we validated a chronic, intermittent, ENDS-based passive vapor exposure model in mice, and then measured changes in multiple behaviors related to nicotine abstinence. First, we performed a behavioral dose curve to investigate the effects of different nicotine inter-vape intervals on various measures including body weight, locomotor activity, and pain hypersensitivity. Next, we performed a pharmacokinetic study to measure plasma levels of nicotine and cotinine following chronic exposure for each inter-vape interval. Finally, we utilized a behavior test battery at a single dosing regimen that produces blood levels equivalent to human smokers in order to characterize the effects of chronic nicotine, vehicle, or passive airflow and identified nicotine-induced impairments in cognitive behavior.

Indexed as

Electronic Nicotine Delivery SystemsNicotineAdolescentAnimalsCognitionCotinineGasesHumansMaleMiceSmokingCotinineGasesNicotineAddictionCognitivee-cigaretteENDSNicotineVaping

Identifiers

PMID38503831
PMCPMC10951409
OpenAlexW4392936038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.